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Introduction
Ischemic neuronal damage remains a common cause of severe neurological disability and death thus making a search for neuroprotective drugs an extremely important issue. Among the early events in ischemia-induced cascades, extracellular calcium entry is of a critical importance as it triggers numerous mechanisms leading to cell damage and death (Fern, 1998; Nowicky and Duchen, 1998) . Blocking of Ca 2+ -permeable NMDA sensitive glutamate receptors markedly reduces the intracellular calcium rise in anoxia (Silver and Erecinska, 1990 ) and was shown to be neuroprotective in neuronal cell cultures (Choi, 1988) and in animal models of focal brain ischemia, hypoglycemia and trauma (Albers et al., 1989) , but not in animal models of transient global ischemia (Buchan and Pulsinelli, 1990) . Moreover, glutamate receptor antagonists revealed disappointing in clinical trials for acute treatment of brain ischemia because of significant side effects (Goldberg, 2005) .
During ischemia, L-type voltage gated calcium channels also ensure an early intracellular calcium rise. Inhibiting L-type voltage gated calcium channels with dihydropyridine abolished the intracellular calcium rise usually observed after 2-4 minutes. No effect however was detected on a small very early intracellular calcium concentration increase (Pisani et al., 1998) . Phase III clinical trials on L-type calcium channels inhibitors all concluded no efficacy (Goldberg, 2005) .
The role of low voltage activated calcium channels (LVAs) during brain ischemia has never been studied. Low voltage activated calcium channels constitute a family of three types of calcium channels commonly referred to as T-type calcium channels: α1G or Ca V 3.1, α1H or Ca V 3.2, α1I or Ca V 3.3 (for review see Perez-Reyes, 2003) . Most brain regions express more than one isoform, and some neurons like olfactory granule cells and hippocampal pyramidal neurons express all three genes (Craig et al., 1999; Kase et al., 1999; Talley et al., 1999 ). An interesting property of T-type calcium channels is the possibility to sustain a continuous 4 This article has not been copyedited and formatted. The final version may differ from this version. calcium influx in neurons and glia at rest by a window current mechanism. The activation and inactivation curves of T-type calcium channels overlap and cross around -60mV. For this reason, a fraction of the channels cycle through all molecular conformations when the membrane potential ranges from -80 to -40mV. Therefore, when neurons are at rest, there is continuously a small fraction of channels that are open and sustain a tiny continuous calcium entry. This property has been shown to produce input signal amplification and bistability in thalamocortical neurons (Williams et al, 1997) . It is implicated in the differentiation of myoblasts (Bijlenga et al., 2000) , neuroendocrine differentiation of human prostate cancer cells (Mariot et al., 2002) and steroidogenesis in adrenal glomerulosa cells (Cohen et al., 1988; Rossier et al., 1998) . Overexpression of T-Type calcium channels in HEK-293 cells has been shown to increase the intracellular calcium concentration (Chemin et al.2000) . The early intracellular calcium concentration increase observed after initiation of an ischemic insult could be the expression of a change in equilibrium between the calcium influx, through T-type calcium channels, and efflux sustained by active mechanisms that dysfunction under metabolic stress.
In the present study we describe the neuroprotective effects of various LVAs inhibitors in a model of in vitro ischemia on rat organotypic hippocampal cultures. These observations support the hypothesis of a critical role for the T-type calcium "window" current during ischemic insult.
Materials and Methods
Immunostaining of transfected HEK-293T cells and hippocampal organotypic cultures
Human embryonic kidney cells (HEK-293T) were transfected as previously described (Chemin et al., 2001 ) using 2.7 µg of different pBK-CMV plasmid constructs that encode for Ca V 3.1 (Chemin et al., 2001) , and Ca V 3.2 . In some experiments, the cells 5 This article has not been copyedited and formatted. The final version may differ from this version. Brideau et al., 1998) to make transfected cells visible by fluorescence. Two days later, cells were harvested and plated on the sterile coverslips. One day later, cells were fixed for 10 min at 4°C in 4% paraformaldehide (PAF) in PBS, preincubated in PBS with 10% fetal calf serum (Gibco, USA) (FCS) and 0.3% Triton X100
for 30 min and incubated with rabbit polyclonal anti-Ca V 3.1 or anti-Ca V 3.2 antibodies (1:500) (Brueggemann et al, 2005) kindly supplied by Dr L. Cribbs (Loyola University Medical Center, Maywood, Illinois), for 24 hours at 4°C. Secondary TRITC or FITC-labeled goat antirabbit IgG antibodies (Chemicon, USA, 1:100 in PBS containing 10% FCS) were applied for 2h at room temperature (RT). Cell nuclei were revealed by Hoescht staining (Sigma, Germany, 0.5mg/ml, 5 min at RT), and the cells were mounted onto Superfrost slides with FluorSave (Merck, USA). Hippocampal organotypic slices were fixed by immersion in 4% PAF solution for 30 min at 4°C and processed for Ca V 3.1 or Ca V 3.2 immunostaining as described above.
Oxygen-glucose deprivation experiments in organotypic hippocampal slice cultures.
Organotypic hippocampal slice cultures were prepared from 7 day old rats and maintained for 11-12 days in culture before the experiments (Stoppini et al., 1991) . Ischemic insult was performed in an interface-type chamber as described (Bancila et al., 2004) . Briefly, after placing the cultures in the chamber, oxygen-glucose deprivation (OGD) was produced by filling the chamber with a gas mixture containing 95% N 2 and 5% CO 2 and perfusing with a medium containing sucrose instead of glucose (in mM: 124 NaCl, 1.6 KCl, 2.5 CaCl 2 , 1.5
MgCl 2 , 24 NaHCO 3 , 1.2 KH 2 PO 4 , 10 sucrose, and 2 ascorbic acid, pH 7.4, temperature 32°C) during 10 min (in the text, the term "ischemia" is also applied to this experimental condition). Except for the condition where post-ischemic effects of mibefradil and nickel were tested, all the drugs were always applied 5 minutes before (to insure diffusion of drugs 6 This article has not been copyedited and formatted. The final version may differ from this version. into cultures) and during the OGD episode. After the challenge, the cultures were placed back in the incubator for recovery in the usual culture medium. To study post-ischemic protection by mibefradil or nickel, drugs were added to the culture medium either just after, or 3 hours, or 6 hours after the OGD insult and maintained in the medium throughout the whole postischemia period.
A few hours before OGD experiments, organotypic slices were transiently treated with propidium iodide (PI, Sigma; 5 µg/ml, 20 min incubation) and observed in a fluorescence microscope (Axioscop 2, Zeiss, Germany) to assess cell viability. Only cultures exhibiting no or very low PI labeling at that stage were selected for the experiments. After the OGD, PI staining was carried out again at 2, 24 and 48 hours, to assess the timing and degree of ischemia-induced cell damage. In all experimental groups and at all time-points, the images of PI staining were taken at the same magnification, exposure time and parameters of the digital camera (Axiocam, Zeiss, Germany). The images were analyzed by using Photoshop®7 software (Adobe Systems Inc.) (Bancila et al., 2004) . Images of the whole hippocampal slice culture were taken and converted to gray scale. We then adjusted the contrast so that the fluorescence precisely matched the contours of labelled pyramidal cell nuclei and then summed the intensity values of all pixels. We verified that these values were proportional to the number of PI labelled nuclei as tested by direct visual counting on specific samples. The result obtained for each slice was then normalized to the mean of 8 slice cultures exposed to OGD under control conditions within the same experiment. All fluorescence data were thus expressed as percent of a control value and then averaged across experiments. Statistical significance was assessed using the unpaired Student t-test.
Evoked transmission experiments in organotypic hippocampal slice cultures.
Slice cultures were placed in a recording chamber and continuously perfused with artificial cerebrospinal fluid containing (in mM) : 124 NaCl, 1.6 KCl, 1.2 KH 2 PO 4 , 24 NaHCO 3 , 10 7 This article has not been copyedited and formatted. The final version may differ from this version. Statistical significance was assessed using the paired Student t-test.
Results
Experiments on HEK-293T expressing recombinant Ca V 3.1 or Ca V 3.2 channels have shown that about 50% of Hoescht labeled cells were stained using antibodies directed against Ca V 3.1 or Ca V 3.2 types of LVAs (Brueggemann et al, 2005) 24 hours after transfection. No immunostaining was observed in non-transfected HEK-293T cells (data not shown). No cross-staining was observed when using anti-Ca V 3.1 antibodies on Ca V 3.2 transfected HEK-293T or vice-versa (Fig. 1A-D) . Thus, antibodies used in our experiments adequately revealed Ca V 3.1 and Ca V 3.2 types of LVAs. These antibodies, when applied to rat organotypic hippocampal cultures, clearly showed labeling in the dentate gyrus, CA3 and CA1 areas (Fig. 1E-F) .
After exposure of organotypic hippocampal slice cultures to a transient (10 min) OGD episode, almost no cell death was observed 2 hours after the insult, while at 24 h and 48 h PI staining showed significant cell damage (Fig. 2, insets) . Delayed cell death was usually observed in the CA1 area and, occasionally, in CA3 and DG regions, if the damage was massive. As revealed in the preliminary experiments by means of electron microscopy, the damage was predominantly attributed to neurons, while glial population was not impaired by cultures, while neurons in all hippocampal areas showed in these conditions the signs of massive immediate death (data not shown). Thus, our in vitro ischemia model reproduces a delayed neuronal cell death similar to that observed in the penumbra region during stroke.
To check whether the induction of this delayed death was calcium dependent, we performed these experiments in conditions of low extracellular calcium (calcium-EGTA buffered at 100 nM calcium) or increased intracellular calcium buffer capacity with BAPTA-AM (10 µM). In both cases we observed significant neuroprotection: less then 20% of propidium iodide fluorescence was detected at 48h compared to control cultures (100%) (Fig 2) .
Application of the LVAs blocker mibefradil during the OGD insult at a concentration of 10 µM protected the cultures very significantly, with 13±5.5 % of PI fluorescence at 48h compared to untreated control cultures (p<0.002). When tested in eGFP/Ca V 3.2 cotransfected HEK cells, 10 µM mibefradil reduced the calcium current by 93±2.7% confirming that at this concentration of the drug the inhibition was almost complete (data not shown).
Also, 10 µM mibefradil applied to hippocampal slice cultures did not significantly affect evoked excitatory transmission and thus did not alter action potential-dependent synaptic mechanisms. Neither the slopes nor the amplitudes nor the ratio of paired pulse evoked excitatory postsynaptic field potentials were significantly affected by more then 15 minutes of mibefradil application (93±6%; 98±5%; 106±8% respectively N=4-5). At 1 µM mibefradil concentration, the neuroprotective effect was reduced, but was still significant, with 39±11% of propidium iodide fluorescence compared to controls (p<0.05). No significant inhibition of the calcium current and no neuronal protection were observed with 0.2 µM mibefradil, showing a clear dose-dependence of the effect. To confirm this, we further tested the effects of other LVAs blockers in our ischemia model. The neuroprotective effect of 350 nM and 500 nM kurtoxin applied during the OGD episode was very significant, with respectively 38%±12% and 10.4%±3.2% of PI fluorescence after the insult compared to control cultures.
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Concurrently, we observed no effect on cell survival with application of 50 nM kurtoxin (Fig.   2) . A strong protection was also obtained with 50 µM nickel, 1 µM zinc and, to a lesser amount, 1 µM pimozide (respectively, 16% ± 6%, 23% ± 2% and 35% ± 8% of propidium iodide fluorescence 48h after the insult compared to controls) (Fig. 2) . These doses of nickel and zinc were also effective in blocking Ca V 3.2 current recorded from eGFP/Ca V 3.2 cotransfected HEK-293T cells (respectively, 85±3.6% and 66±8.5% inhibition, data not shown).
We measured the effect of the inhibition of high voltage activated calcium channels with 10µM nifedipine on delayed neuronal death in the same conditions as used when inhibiting low voltage activated calcium channels. In this case, no significant reduction of PI fluorescence was observed (84 ± 22%, data not shown).
Interestingly, mibefradil at a concentration of 10 µM or nickel at a concentration of 50 µM were also neuroprotective if applied not during the insult, but immediately after and during the remaining 48h of the experiment. Compared to control cultures, PI fluorescence at 48h was reduced to 21±5% in mibefradil-treated cultures and to 19±3% in nickel-treated cultures (p<0.05). A smaller but still significant protective effect was also observed when mibefradil or nickel were added to the culture medium 3 hours after the OGD insult, with 53±10% and 60%±15% of PI fluorescence at 48h respectively (p<0.03). However, no significant protection was observed when mibefradil treatment was started six hours after the OGD episode (Fig. 3) .
Discussion
Much evidence indicates that a small and slow intracellular calcium concentration increase takes place during the early phase corresponding to the first 2 to 3 minutes of ischemia. It starts just after cells transiently alkalinize secondarily to the hydrolysis of phosphocreatins (Silver and Erecinska, 1990) . It has been observed in vivo and in vitro in acute hippocampal
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This article has not been copyedited and formatted. The final version may differ from this version. (Pisani et al., 1998) . The origin of the calcium increase has been demonstrated to be extracellular, while intracellular and mitochondrial calcium stores seem not to be involved (Nowicky and Duchen, 1998) . High voltage activated calcium channels have been proposed as a potential entry pathway for calcium, but application of dihydropyridine in animal studies (Silver and Erecinska, 1990) and in dissociated cortical neurons (Pisani et al., 1998) either did not modify the calcium concentration increase profile over time, or only acted on a delayed component.
Low voltage activated calcium channels have been suggested to be an important factor for intracellular glial calcium increase and cell death during ischemia in neonatal rat optical nerve white matter (Fern, 1998) . The aim of the present study was to evaluate the effect of inhibition of T-type calcium current on delayed post-ischemic neuronal death in hippocampal neurons.
In rat hippocampal organotypic cultures used in our in vitro ischemia model, low voltage activated calcium channels Ca V 3.1 and Ca V 3.2 are indeed expressed in CA1, CA3 and dentate gyrus areas, as shown by immunochemistry. The fact that significantly less neurons suffer delayed neuronal death when exposed to low extracellular calcium or after increasing the intracellular calcium buffering ability during the OGD insult confirms the calciumdependence of delayed cell death and correlates with earlier observations (Abdel-Hamid and Tymianski, 1997) .
In resting neurons and glia, the intracellular calcium concentration is maintained by the equilibrium between a constant passive calcium influx and an energy-consuming pumping.
T-type voltage gated calcium channels sustain a small but constant calcium current at membrane potential between -80 and -40mV (Bijlenga et al 2000) . At rest, neurons and glia are hyperpolarized close to -70mV. We expect that in resting neurons and glia calcium continuously flows in through voltage activated T-type calcium channels. During ischemia,
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This article has not been copyedited and formatted. The final version may differ from this version. Reducing or abolishing the calcium influx would be beneficial by itself, and would also spare energy for other essential house keeping cellular activities. In line with this hypothesis, we show here that pharmacological inhibition of the T-type calcium current by LVAs blockers mibefradil, kurtoxin, nickel, zinc and pimozide at effective concentrations that inhibit more then 80% of the current provides a very significant protection against delayed neuronal death.
All these drugs are selective LVAs inhibitors, although most of them have additional effects.
Mibefradil was described as a first selective T-type calcium current blocker (Clozel et al., 1997) , but it has been also shown to block delayed rectifier potassium channels (K dr ) at similar concentrations, to significantly inhibit L-type calcium channels (Liu et al., 1999) and block in a state-dependent manner sodium channels (McNulty and Hanck 2004) . The effects observed here are however unlikely to be due to a block of sodium channels, since it could be reproduced by all other calcium channel antagonists used and since mibefradil did not significantly affect evoked action potential-dependent synaptic transmission under those conditions. Among other blockers tested, at the concentration used in our experiments, nickel is a traditional T-type calcium current blocker (Hille, 2001) . Other divalent metals like Cu 2+
and Zn 2+ have also been recently described to be selective T-type calcium inhibitors (Jeong et al., 2003) . At small concentrations, as used in our experiments, zinc also activates ATP sensitive potassium channels (K ATP ) (Bancila et al., 2004; Bloc et al., 2000) . Kurtoxin is a peptide purified from scorpion venom and was reported to bind with high affinity to Ca V 3.1 type LVAs and inhibit the T-type calcium current by modifying the channel gating. This toxin was shown to distinguish between T-type calcium channels and high voltage activated calcium channels (Chuang et al., 1998; Sidach and Mintz, 2002) . At concentration of 350 nM, kurtoxin was reported to inhibit almost totally the current of Ca V 3.1 channels and 80% of Ca V 3.2 channels' current, while Ca V 3.3 type seems to be resistant 12 This article has not been copyedited and formatted. The final version may differ from this version. . Recently pimozide, a neuroleptic drug, has also been described to be a selective T-type calcium channel blocker with a half-inhibition concentration estimated at ~100 nM for all Ca V 3 channels, although Ca V 3.2 is less sensitive (Santi et al., 2002) . It is 10 times more selective for LVAs than for high voltage activated calcium channels. To exclude the possibility that neuroprotective effect observed with LVAs inhibitors is in fact a non specific effect due to inhibition of high voltage activated calcium channels, we inhibited L-type calcium current with nifedipine and performed OGD. In our conditions we observed no significant protection against delayed neuronal death.
Recently Rekling (Rekling, 2003) reported the neuroprotective effect of anticonvulsants on organotypic hippocampal cultures subjected to transient ischemia. Interestingly, ethosuximide, phenobarbital and phenytoine reported to be the most neuroprotective anticonvulsants are also the drugs with the most potent T-type calcium current inhibitory activity (respectively EC 50 = 23,7µM, 1,7 µM, 7,3 µΜ) (Todorovic and Lingle, 1998; Todorovic et al., 2000) .
In spite of the different pharmacological profiles of the LVAs blockers tested, all of them act as potent T-type calcium current inhibitors, and all of them ensured significant neuroprotection after a transient OGD in our experiments. The converging neuroprotective effects of these various drugs which, at the concentrations used, exhibit selectivity for T-type calcium channels support the hypothesis suggesting an important role of LVAs in ischemiainduced cell damage. As the effect may not only be neuroprotective when the drugs are applied during the OGD episode, as shown with mibefradil and nickel, but also when applied shortly after the insult, these data open new perspectives of possible pharmacological approaches to neuroprotection.
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